{"title":"A \"20/20\" Match: ACC/AHA 2017 versus ESC/ESH 2018 Guidelines for Management of Hypertension.","authors":"Akshyaya Pradhan, Shweta Vohra, Rishi Sethi","doi":"10.1055/s-0041-1732433","DOIUrl":"https://doi.org/10.1055/s-0041-1732433","url":null,"abstract":"<p><p>Hypertension, the commonest noncommunicable disease globally, is an important risk factor for cardiovascular disease and renal failure. Theoretically, while it is easy to diagnose and manage by simple measures, practically it has been observed that not only treatment but also diagnosis and its preventive measures are inadequate in developing as well as developed nations. Several guidelines by various international organizations are available to guide clinicians for hypertension management. Though the basic principles of hypertension management are similar in all the guidelines, subtle differences are there. In this article, we compare the two most widely accepted guidelines for hypertension, that is, American College of Cardiology/American Heart Association 2017 Hypertension Guidelines and 2018 European Society of Cardiology and European Society of Hypertension Guidelines on Hypertension. Both the differences and similarities between these two widely followed guidelines are presented.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 4","pages":"243-248"},"PeriodicalIF":0.6,"publicationDate":"2021-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608471/pdf/10-1055-s-0041-1732433.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39936265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tuncay Taskesen, Kofi Osei, Russell Hamilton, Justin Ugwu, Daniel Shivapour, Mark Tannenbaum, Magdi Ghali
{"title":"Coronary Artery Fistulae in Adult: Two Decades of Experience in Clinical Presentation, Angiographic Feature, and Management.","authors":"Tuncay Taskesen, Kofi Osei, Russell Hamilton, Justin Ugwu, Daniel Shivapour, Mark Tannenbaum, Magdi Ghali","doi":"10.1055/s-0041-1727134","DOIUrl":"https://doi.org/10.1055/s-0041-1727134","url":null,"abstract":"<p><p>Coronary artery fistula (CAF) in adults is a rare but significant coronary artery anomaly. Main data on that rare disease were mostly obtained from case reports and small studies. In presented study, we share our two-decade experience on the clinical and angiographic characteristics of CAF. The data were collected retrospectively by analyzing the angiographic data between January 1, 2000 and December 31, 2019. Demographic data, clinical data, laboratory, and cardiac catheterization reports were reviewed. CAFs were found in 40 patients (0.06%). There were 22 male (55%) patients. The mean age was 61.2 years. Twenty-nine patients (72.5%) had small, 4 patients (10%) had medium, and 7 patients (17.5%) had large CAFs. The majority of study population had solitary CAF ( <i>n</i> = 31, 77.5%). The pulmonary artery is the major side of fistula drainage ( <i>n</i> = 20, 50%). The study population was divided into two groups as follow: group 1-small CAFs 29 (72.5%), group 2-medium and large CAF (MLCAF) 11 (27.5%). Patients with MLCAFs had more atrial fibrillation, abnormal coronary morphology, and multiple fistulae. In patients with hemodynamically significant CAFs, 7 (17.5%) patients had surgical ligation and 3 (7.5%) patients had transcutaneous closure. Three patients died during mean follow-up period of 5 years. The incidence and the pattern of CAFs in our study were similar to previous studies. Clinical course of small fistulae was benign. Symptomatic MLCAFs need to be treated by transcatheter or surgical way and should be individualized per patient.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 4","pages":"277-284"},"PeriodicalIF":0.6,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608461/pdf/10-1055-s-0041-1727134.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39936270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Lambert, Allan Mattia, Angel Hsu, Frank Manetta
{"title":"CABG versus PCI in the Treatment of Unprotected Left Main Disease in Diabetics: A Literature Review.","authors":"Daniel Lambert, Allan Mattia, Angel Hsu, Frank Manetta","doi":"10.1055/s-0041-1735517","DOIUrl":"https://doi.org/10.1055/s-0041-1735517","url":null,"abstract":"<p><p>The approach to left main coronary artery disease (CAD) in diabetic patients has been extensively debated. Diabetic patients have an elevated risk of left main disease in addition to multivessel disease. Previous trials have shown increased revascularization rates in percutaneous coronary intervention compared with coronary artery bypass grafting (CABG) but overall comparable outcomes, although many of these studies were not using the latest stent technology or CABG with arterial revascularization. Our aim is to review the most recent trials that have recently published long-term follow-up, as well as other literature pertaining to left main disease in diabetic patients. Furthermore, we will be discussing some future treatment strategies that could likely create a paradigm shift in how left main CAD is managed.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 3","pages":"187-193"},"PeriodicalIF":0.6,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580609/pdf/10-1055-s-0041-1735517.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39711679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Current and Future Options in the Prevention and Treatment of Coronary Artery Disease with Special Reference to Surgical Aspect: Part II.","authors":"Kailash Prasad, John A Elefteriades","doi":"10.1055/s-0041-1735610","DOIUrl":"https://doi.org/10.1055/s-0041-1735610","url":null,"abstract":"","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 3","pages":"175-176"},"PeriodicalIF":0.6,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580604/pdf/10-1055-s-0041-1735610.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39711678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew A Brown, Seth Klusewitz, John Elefteriades, Lindsey Prescher
{"title":"The Current State of Coronary Revascularization: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery.","authors":"Matthew A Brown, Seth Klusewitz, John Elefteriades, Lindsey Prescher","doi":"10.1055/s-0041-1735591","DOIUrl":"10.1055/s-0041-1735591","url":null,"abstract":"<p><p>The question of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery remains among the most important questions in the treatment of coronary artery disease. The leading North American and European societies largely agree on the current guidelines for the revascularization of unprotected left-main disease (ULMD) and multivessel disease (MVD) which are largely supported by the outcomes of several large randomized trials including SYNTAX, PRECOMBAT, NOBLE, and EXCEL. While these trials are of the highest quality, currently available, they suffer several limitations, including the use of bare metal and/or first-generation drug-eluting stents in early trials and lack of updated surgical outcomes data. The objective of this review is to briefly discuss these key early trials, as well as explore contemporary studies, to provide insight on the current state of coronary revascularization. Evidence suggests that in ULMD and MVD, there are similar mortality rates for CABG and PCI but PCI is associated with fewer \"early\" strokes, whereas CABG is associated with fewer \"late\" strokes, myocardial infarctions, and lower need for repeat revascularization. Additionally, studies suggest that CABG remains superior to PCI in patients with intermediate/high SYNTAX scores and in MVD with concomitant proximal left anterior descending (pLAD) artery stenosis. Despite the preceding research and its basis for our current guidelines, there remains significant variation in care that has yet to be quantified. Emerging studies evaluating second-generation drug-eluting stents, specific lesion anatomy, and minimally invasive and hybrid approaches to CABG may lend itself to more individualized patient care.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 3","pages":"228-242"},"PeriodicalIF":0.5,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580607/pdf/10-1055-s-0041-1735591.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39622579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Raka A Nugraha, Hary S Muliawan, Nyityasmono T Nugroho, Muhammad Ikhsan, Suko Adiarto
{"title":"Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient.","authors":"Raka A Nugraha, Hary S Muliawan, Nyityasmono T Nugroho, Muhammad Ikhsan, Suko Adiarto","doi":"10.1055/s-0041-1735200","DOIUrl":"10.1055/s-0041-1735200","url":null,"abstract":"<p><p>Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"32 3","pages":"197-201"},"PeriodicalIF":0.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421675/pdf/10-1055-s-0041-1735200.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10371906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sidhi Laksono, B. Setianto, Mohammad Iqbal, A. S. Prawara
{"title":"Understanding Pacemaker-Induced Cardiomyopathy Incidence and Predictors in Patients with Right Ventricular Pacing: A Systematic Review","authors":"Sidhi Laksono, B. Setianto, Mohammad Iqbal, A. S. Prawara","doi":"10.1055/s-0041-1735206","DOIUrl":"https://doi.org/10.1055/s-0041-1735206","url":null,"abstract":"Abstract This study aimed to figure out the incidence and predictors of pacemaker-induced cardiomyopathy (PICM) in patients with right ventricular (RV) pacing. We systematically searched in PubMed on March 18, 2020, for English language abstract and full-article journals, using the following criteria: pacemaker induced cardiomyopathy AND right ventricular AND pacemaker AND patients AND human NOT implantable cardioverter defibrillator NOT ICD NOT animal. Four studies were included in this review after filtering 35 studies through year of publication and abstract selection. The average PICM incidence from 1,365 patients included from the four studies was 10.7 to 13.7%. One study stated that preimplantation left ventricular ejection fraction (LVEF) was the predictor for the development of PICM. Three studies mentioned that RV pacing burden was the predictor for the development of PICM. However, the percentage differ in three studies: ≥20, >40, and 60%. In addition, one of the studies also included interventricular dyssynchrony as another predictor. The incidence of PICM in patients with RV pacing ranged from 10.7 to 13.7%. Preimplantation LVEF, interventricular dyssynchrony, and burden of RV pacing are reported as the predictors for the development of PICM in patients with RV pacing.","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47619912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Suko Adiarto, Novi Kurnianingsih, Indra Prasetya, Faris W Nugroho, Raman Uberoi
{"title":"Successful Primary PCI in Stanford Type A Aortic Dissection Complicated by Inferior ST-Elevation Myocardial Infarction: A Case in a Facility with No Surgical Backup.","authors":"Suko Adiarto, Novi Kurnianingsih, Indra Prasetya, Faris W Nugroho, Raman Uberoi","doi":"10.1055/s-0041-1735205","DOIUrl":"10.1055/s-0041-1735205","url":null,"abstract":"<p><p>Mortality of type A aortic dissection (TAAD) complicated with coronary malperfusion syndrome is very high even when emergency surgery is performed. Several reports suggested that primary percutaneous coronary intervention (PPCI) followed by immediate corrective surgery may reduce mortality. In many countries, immediate transfer to an aortic surgery center may not be possible. We report a case of TAAD complicated by coronary malperfusion successfully treated with PPCI followed by elective corrective surgery. A 48-year-old man was referred to emergency department with acute inferior ST-elevation myocardial infarction (STEMI) and underwent PPCI. During the procedure, we realized that the cause of STEMI was TAAD. We decided to continue because the patient experienced seizures and bradycardia. Subsequently, echocardiography and computed tomography confirmed the dissection. The patient was discharged and referred to the National Cardiovascular Center where he underwent successful elective surgery. In this patient, immediate revascularization was lifesaving and served as a bridging procedure before surgical correction.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"1 1","pages":"62-65"},"PeriodicalIF":0.6,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10861288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41573171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Relevant Nomenclature Considerations during Coronary Artery Contrast Injection.","authors":"Brett Thomas Snodgrass","doi":"10.1055/s-0041-1735202","DOIUrl":"https://doi.org/10.1055/s-0041-1735202","url":null,"abstract":"Note: This letter is a reply to: Valencia D, Linares J, Das S, ValenciaV,YatsynovichY.UncommonCoronaryAbnormalities in a Patient with Discoid Lupus Erythematosus. Int J Angiol. 2020 Dec;29(4):260–262. doi: 10.1055/s-0039-1696978. Epub 2019 Sep 12. PMID: 33268978; PMCID: PMC7690985. Fig. 3B in the report by Valencia et al1 states that the image demonstrates connections between the coronary veins and the heart chambers. The arrow heads are reported to be connections between the coronary veins and heart chambers.1 However, the right-most arrow head is adjacent to a contrast-dense vessel which appears to be a distributary of the injected right coronary artery. Instead of a connection between the coronary vein and heart chamber, this appears to be a connection between the coronary artery and heart chamber, similar to the vessels described byWearn et al and noted by other angiographers.2 Parenthetically, the arterial-cameral connections first reported by Vieussens in 17063 and later described byWearn in 19334 are distinct from the vein-cameral connection first reported by Thebesius in 1708.5 In conclusion, the authors1 appear to demonstrate cardiac arteriocameral connections and not cardiac venocameral connections. Funding None.","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"30 4","pages":"298"},"PeriodicalIF":0.6,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608474/pdf/10-1055-s-0041-1735202.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39936272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Laser Doppler Measurements of Systolic Blood Pressure on the First and Second Toe in Patients with Peripheral Arterial Disease","authors":"S. Rosfors, A. Modin, J. Petrini","doi":"10.1055/s-0041-1735237","DOIUrl":"https://doi.org/10.1055/s-0041-1735237","url":null,"abstract":"Abstract Laser Doppler was used to measure toe blood pressure (TBP) in 40 consecutive patients with various degree of peripheral arterial disease. The aim of this methodological study was to increase the usefulness of TBP by exploring the interchangeability between TBP from the first and second toe and by investigating daily routine reproducibility and measurement variability. According to our study design pressure values were based on three measurements that were averaged. At simultaneous measurements, TBP of the first toe was 71 mm Hg (standard deviation [SD] 25) compared with 70 mm Hg (SD 25) on the second toe. The correlation (r) between first and second toe pressure measurements was 0.84 and intraclass correlation coefficient (ICC) was 0.84. The difference between TBP on the first and second toe was not related to gender, diabetes, or magnitude of the pressures. Repeated TBP measurements of the right first toe after disconnection of cuffs, 5 to 10 minutes rest, and reconnection of cuffs had a coefficient of variation (CV) of 9% and an ICC of 0.93. CV for toe-brachial index (TBI) was 8%. Our results show that measurements of TBP from the second toe to a large extent are interchangeable with those assessed from the first toe and can be used in clinical situations where measurements from the first toe are not feasible. Flow detection with three averaged laser Doppler measurements generates TBP and TBI with low variability.","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2021-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47457319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}